As of 10:40am ET
| -0.22 / -1.50%|
The 8 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 17.50, with a high estimate of 23.00 and a low estimate of 16.00. The median estimate represents a +20.77% increase from the last price of 14.49.
The current consensus among 9 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.